kentucky semaglutide gastric stasis attorney michigan legal team glp-1 gastroparesis in michigan glp-1 gastric stasis lawyer in michigan Repurposing glucagon-like peptide-1 receptor agonists for the-camerecole-mvanhaasteren.nl Ozempic® Lawsuit | July 2026

24/7 Customer Support: We have a team of live reps ready to help and answer any questions you have within a 24-hour time frame, 7 days a week.

Long-term GLP-1 medication use shows cardiovascular benefits in trials, but emerging data on bone health and pancreatitis risk requires ongoing monitoring

The makers of Ozempic and Mounjaro, drugs used for both weight loss and diabetes management, are facing a lawsuit claiming the medications can cause "stomach paralysis." Janet Shamlian reports.

Glucagon-like peptide-1 receptor (GLP-1R) is a versatile therapeutic target that regulates glucose homeostasis, cardiovascular function, neuroprotection, and immune responses

The perfect combination of performance and taste

The incretin hormone glucagon-like peptide 1 (GLP-1) has been implicated in the gutrenal axis and incretin-based therapies might reduce the burden of diabetic kidney disease